533 related articles for article (PubMed ID: 12543894)
21. [Measuring the content of reticulocyte hemoglobin (CHr) in predialysis chronic renal failure (CRF) patients].
Saito M; Tsuchiya K; Ando M; Akiba T; Nihei H
Nihon Jinzo Gakkai Shi; 2003 Jul; 45(5):430-8. PubMed ID: 14509218
[TBL] [Abstract][Full Text] [Related]
22. Serum soluble transferrin receptor reflects erythropoiesis but not iron availability in erythropoietin-treated chronic hemodialysis patients.
Chiang WC; Tsai TJ; Chen YM; Lin SL; Hsieh BS
Clin Nephrol; 2002 Nov; 58(5):363-9. PubMed ID: 12425487
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of a low-dose intravenous iron sucrose regimen in peritoneal dialysis patients.
Dittrich E; Schillinger M; Sunder-Plassmann G; Hörl WH; Vychytil A
Perit Dial Int; 2002; 22(1):60-6. PubMed ID: 11929146
[TBL] [Abstract][Full Text] [Related]
24. Comparison of two iron gluconate treatment modalities in chronic hemodialysis patients: results of a randomized trial.
Giordano A; Arrigo G; Lavarda F; Colasanti G; Petrini C
J Nephrol; 2005; 18(2):181-7. PubMed ID: 15931646
[TBL] [Abstract][Full Text] [Related]
25. Hypochromic erythrocytes (%): a reliable marker for recognizing iron-restricted erythropoiesis and predicting response to erythropoietin in anemic patients with myeloma and lymphoma.
Katodritou E; Terpos E; Zervas K; Speletas M; Kapetanos D; Kartsios C; Verrou E; Banti A; Effraimidou S; Christakis J
Ann Hematol; 2007 May; 86(5):369-76. PubMed ID: 17375302
[TBL] [Abstract][Full Text] [Related]
26. The target hemoglobin content values of reticulocytes for efficient anemia improvement are achieved by low ferritin levels and moderate transferrin saturation: a retrospective observational study.
Ogawa C; Tsuchiya K; Tomosugi N; Shimada K; Kanda F; Maeda K
Hematology; 2020 Dec; 25(1):71-78. PubMed ID: 32009585
[No Abstract] [Full Text] [Related]
27. Intravenous ascorbic acid as an adjuvant therapy for recombinant erythropoietin in hemodialysis patients with hyperferritinemia.
Tarng DC; Wei YH; Huang TP; Kuo BI; Yang WC
Kidney Int; 1999 Jun; 55(6):2477-86. PubMed ID: 10354297
[TBL] [Abstract][Full Text] [Related]
28. Reticulocyte hemoglobin content in hemodialysis patients with acute infection.
Mitsuiki K; Harada A; Miyata Y
Clin Exp Nephrol; 2004 Sep; 8(3):257-62. PubMed ID: 15480904
[TBL] [Abstract][Full Text] [Related]
29. Markers of masked iron deficiency and effectiveness of EPO therapy in chronic renal failure.
Ahluwalia N; Skikne BS; Savin V; Chonko A
Am J Kidney Dis; 1997 Oct; 30(4):532-41. PubMed ID: 9328369
[TBL] [Abstract][Full Text] [Related]
30. Determinants of circulating soluble transferrin receptor level in chronic haemodialysis patients.
Tarng DC; Huang TP
Nephrol Dial Transplant; 2002 Jun; 17(6):1063-9. PubMed ID: 12032198
[TBL] [Abstract][Full Text] [Related]
31. Diagnosis of iron deficiency in hemodialysis patients: Usefulness of measuring reticulocyte hemoglobin equivalent.
Sany D; El Shahawi Y; Taha J
Saudi J Kidney Dis Transpl; 2020; 31(6):1263-1272. PubMed ID: 33565438
[TBL] [Abstract][Full Text] [Related]
32. The usefulness of reticulocyte haemoglobin content, serum transferrin receptor and the sTfR-ferritin index to identify iron deficiency in healthy children aged 1-16 years.
Vázquez-López MA; López-Ruzafa E; Ibáñez-Alcalde M; Martín-González M; Bonillo-Perales A; Lendínez-Molinos F
Eur J Pediatr; 2019 Jan; 178(1):41-49. PubMed ID: 30264352
[TBL] [Abstract][Full Text] [Related]
33. A randomized, controlled parallel-group trial on efficacy and safety of iron sucrose (Venofer) vs iron gluconate (Ferrlecit) in haemodialysis patients treated with rHuEpo.
Kosch M; Bahner U; Bettger H; Matzkies F; Teschner M; Schaefer RM
Nephrol Dial Transplant; 2001 Jun; 16(6):1239-44. PubMed ID: 11390726
[TBL] [Abstract][Full Text] [Related]
34. A comparison of oral and intravenous iron supplementation in preterm infants receiving recombinant erythropoietin.
Meyer MP; Haworth C; Meyer JH; Commerford A
J Pediatr; 1996 Aug; 129(2):258-63. PubMed ID: 8765624
[TBL] [Abstract][Full Text] [Related]
35. Usefulness of Reticulocyte Hemoglobin Equivalent in Management of Regular Hemodialysis Patients with Iron Deficiency Anemia.
Dalimunthe NN; Lubis AR
Rom J Intern Med; 2016; 54(1):31-6. PubMed ID: 27141568
[TBL] [Abstract][Full Text] [Related]
36. Soluble transferrin receptors and reticulocyte hemoglobin concentration in the assessment of iron deficiency in hemodialysis patients.
Fusaro M; Munaretto G; Spinello M; Rebeschini M; Amici G; Gallieni M; Piccoli A
J Nephrol; 2005; 18(1):72-9. PubMed ID: 15772926
[TBL] [Abstract][Full Text] [Related]
37. Reticulocyte hemoglobin equivalent: an indicator of reduced iron availability in chronic kidney diseases during erythropoietin therapy.
Garzia M; Di Mario A; Ferraro E; Tazza L; Rossi E; Luciani G; Zini G
Lab Hematol; 2007; 13(1):6-11. PubMed ID: 17353176
[TBL] [Abstract][Full Text] [Related]
38. The Role of Reticulocyte Hemoglobin Content for Diagnosis of Iron Deficiency and Iron Deficiency Anemia, and Monitoring of Iron Therapy: a Literature Review.
Gelaw Y; Woldu B; Melku M
Clin Lab; 2019 Dec; 65(12):. PubMed ID: 31850722
[TBL] [Abstract][Full Text] [Related]
39. Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants.
Pollak A; Hayde M; Hayn M; Herkner K; Lombard KA; Lubec G; Weninger M; Widness JA
Pediatrics; 2001 Jan; 107(1):78-85. PubMed ID: 11134438
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
